Cost–effectiveness of amiodarone in cardiac surgery

References

• Hilleman DE, Hunter CB, Mohiuddin SM, Maciejewski S. Pharmacological management of atrial fibrillation following cardiac surgery. Am. J. Cardiovasc. Drugs5, 361–369 (2005).
   PubMedGoogle Scholar
• Frost L, Molgaard H, Christiansen EH, Hjortholm K, Paulsen PK, Thomsen PE. Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials. Int. J. Cardiol.36, 253–261 (1992).
   PubMed Web of Science ®Google Scholar
• Fuller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J. Thorac. Cardiovasc. Surg.97, 821–825 (1989).
   PubMed Web of Science ®Google Scholar
• Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Prog. Cardiovasc. Dis.31, 367–378 (1989).
   PubMed Web of Science ®Google Scholar
• Mathew JP, Parks R, Savino JS et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA276, 300–306 (1996).
   PubMed Web of Science ®Google Scholar
• Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N. Engl. J. Med.336, 1429–1434 (1997).
   PubMed Web of Science ®Google Scholar
• Page PL, Pym J. Atrial fibrillation following cardiac surgery. Can. J. Cardiol.12 (Suppl. A), 40A–44A (1996).
   Google Scholar
• Mathew JP, Fontes ML, Tudor IC et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA291, 1720–1729 (2004).
   PubMed Web of Science ®Google Scholar
• Taylor GJ, Malik SA, Colliver JA et al. Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. Am. J. Cardiol.60, 905–907 (1987).
   PubMed Web of Science ®Google Scholar
• Rubin DA, Nieminski KE, Reed GE, Herman MV. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. J. Thorac. Cardiovasc. Surg.94, 331–335 (1987).
   PubMed Web of Science ®Google Scholar
• Ali IM, Sanalla AA, Clark V. β-blocker effects on postoperative atrial fibrillation. Eur J. Cardiothorac. Surg.11, 1154–1157 (1997).
   PubMedGoogle Scholar
• Hashimoto K, Ilstrup DM, Schaff HV. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J. Thorac. Cardiovasc. Surg.101, 56–65 (1991).
   PubMed Web of Science ®Google Scholar
• Silverman NA, Wright R, Levitsky S. Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Ann. Surg.196, 194–197 (1982).
   PubMedGoogle Scholar
• Goldstein LB, Adams R, Becker K et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation103, 163–182 (2001).
   PubMed Web of Science ®Google Scholar
• Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann. Thorac. Surg.56, 539–549 (1993).
   PubMed Web of Science ®Google Scholar
• Aranki SF, Shaw DP, Adams DH et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation94, 390–397 (1996).
   PubMed Web of Science ®Google Scholar
• Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J. Am. Coll. Cardiol.48, e149–e246 (2006).
   Web of Science ®Google Scholar
• McKeown PP, Gutterman D. Executive summary: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest128, S1–S5 (2005).
   PubMed Web of Science ®Google Scholar
• Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database. Syst. Rev.CD003611 (2004).
   Google Scholar
• Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. Am. J. Ophthalmol.130, 688 (2000).
   PubMedGoogle Scholar
• Concato J. Observational versus experimental studies: what's the evidence for a hierarchy? NeuroRx1, 341–347 (2004).
   PubMedGoogle Scholar
• Pacerone package insert. Upsher-Smith Laboratories, Inc, Minneapolis, MN, USA (2006).
   Google Scholar
• Redbook. Pharmacy’s Fundamental Reference. Medical Economics Thompson Healthcare, Montvale, NJ, USA, 218 (2005).
   Google Scholar
• Gillespie EL, Coleman CI, Sander S, Kluger J, Gryskiewicz KA, White CM. Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann. Pharmacother.39, 1409–1415 (2005).
   PubMed Web of Science ®Google Scholar
• Zimmer J, Pezzullo J, Choucair W et al. Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am. J. Cardiol.91, 1137–1140 (2003).
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, Galbraith PD, Mitchell LB, Sauve R, Exner DV, Ghali WA. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann. Thorac. Surg.82, 1927–1937 (2006).
   PubMed Web of Science ®Google Scholar
• Daoud EG, Strickberger SA, Man KC et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N. Engl. J. Med.337, 1785–1791 (1997).
   PubMed Web of Science ®Google Scholar
• Giri S, White CM, Dunn AB et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet357, 830–836 (2001).
   PubMed Web of Science ®Google Scholar
• Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. J. Am. Coll. Cardiol.34, 343–347 (1999).
   PubMed Web of Science ®Google Scholar
• Lee SH, Chang CM, Lu MJ et al. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann. Thorac. Surg.70, 157–161 (2000).
   PubMed Web of Science ®Google Scholar
• Redle JD, Khurana S, Marzan R et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am. Heart. J.138, 144–150 (1999).
   PubMed Web of Science ®Google Scholar
• White CM, Caron MF, Kalus JS et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation108(Suppl 1), II200–II206 (1999)
   Google Scholar
• Reddy P, Kalus JS, Caron MF et al. Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery. Pharmacotherapy24, 1013–1019 (2004).
   PubMedGoogle Scholar
• Kerstein J, Soodan A, Qamar M et al. Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. Chest126, 716–724 (2004).
   PubMedGoogle Scholar
• Kim MH, Rachwal W, McHale et al. Effect of amiodarone ± diltiazem ± β blocker on frequency of atrial fibrillation, length of hospitalization, and hospital costs after coronary artery bypass grafting. Am. J. Cardiol.89, 1126–1128 (2002).
   PubMedGoogle Scholar
• Barnes BJ, Kirkland EA, Howard PA et al. Risk-stratified evaluation of amiodarone to prevent atrial fibrillation after cardiac surgery. Ann. Thorac. Surg.82, 1332–1337 (2006).
   PubMedGoogle Scholar
• Gillespie EL, White CM, Kluger J, Rancourt JA, Gallagher R, Coleman CI. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy26, 499–504 (2006).
   PubMedGoogle Scholar
• Perkerson KA, Gillespie EL, White CM et al. Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery. Pharmacotherapy25, 320–324 (2005).
   PubMedGoogle Scholar
• Reddy P, Richerson M, Freeman-Bosco L, Dunn A, White CM, Chow MS. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation in coronary artery bypass surgery. Am. J. Health. Syst. Pharm.56, 2211–2217 (1999).
   PubMedGoogle Scholar
• Reddy P, Gao X, Burrell A, Boci K, Bouin O. Cost-effectiveness of amiodarone to prevent atrial fibrillation after cardiac surgery. 10th ISPOR Annual International Meeting. Washington DC, USA, PCV 9 (2005).
   Google Scholar
• Aasbo JD, Lawrence AT, Krishnan K, Kim MH, Trohman RG. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann. Intern. Med.143, 327–336 (2005).
   PubMed Web of Science ®Google Scholar
• Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur. Heart. J.27, 2846–2857 (2006).
   PubMed Web of Science ®Google Scholar
• Auer J, Weber T, Berent R et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Am. Heart. J.147, 636–643 (2004).
   PubMed Web of Science ®Google Scholar
• Maras D, Boskovic SD, Popovic Z et al. Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery. Am. Heart. J.141, E8 (2001).
   PubMedGoogle Scholar
• Mitchell LB, Exner DV, Wyse DG et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. JAMA294, 3093–3100 (2005).
   PubMed Web of Science ®Google Scholar
• Solomon AJ, Greenberg MD, Kilborn MJ, Katz NM. Amiodarone versus a β-blocker to prevent atrial fibrillation after cardiovascular surgery. Am. Heart J.142, 811–815 (2001).
   PubMed Web of Science ®Google Scholar
• Yagdi T, Nalbantgil S, Ayik F et al. Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg.125, 1420–1425 (2003).
   PubMed Web of Science ®Google Scholar
• Mahoney EM, Thompson TD, Veledar E, Williams J, Weintraub WS. Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J. Am. Coll. Cardiol.40, 737–745 (2002).
   PubMed Web of Science ®Google Scholar
• Weber UK, Osswald S, Huber M et al. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur. Heart. J.19, 794–800 (1998).
   PubMed Web of Science ®Google Scholar
• Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Gold MR (Ed.), Weinstein MC (Ed.), Oxford University Press, New York, NY, USA (1996).
   Google Scholar
• Dorge H, Schoendube FA, Schoberer M, Stellbrink C, Voss M, Messmer BJ. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. Ann. Thorac. Surg.69, 1358–1362 (2000).
   PubMed Web of Science ®Google Scholar